Further in vitro, in silico and mouse model experiments using our recently developed orthotopic HGSOC models (17) led us to conclude that TGFBI is an important component of tumor microenvironments at different sites and stages of HGSOC and that it may contribute to immunosuppression and disease progression. The gene discussed is TGFBI; the disease is neoplasm.